Science & Research Staff Directory
CAMH is a leader in mental health research, with more than 120 scientists at the core of our research enterprise.
Meet Our Scientists
Dr. Tony P. George
Senior Scientist, Institute for Mental Health Policy Research
tony.george@camh.ca About Dr. Tony P. George
Dr. Philip Gerretsen
Senior Scientist, Brain Health Imaging Centre & Pre-Clinical Research and Adult Neurodevelopment and Geriatric Psychiatry
philip.gerretsen@camh.ca About Dr. Philip Gerretsen
Dr. Benjamin Goldstein
Scientific Director, Centre for Youth Bipolar Disorder
benjamin.goldstein@camh.ca About Dr. Benjamin Goldstein
Dr. Vanessa Gonçalves
Scientist, Molecular Science
Vanessa.Goncalves@camh.ca About Dr. Vanessa Gonçalves
Dr. Ariel Graff
Senior Scientist, Brain Health Imaging Centre and Adult Neurodevelopment and Geriatric Psychiatry Division
ariel.graff@camh.ca About Dr. Ariel Graff
Dr. Sylvain Houle
Senior Scientist Emeritus, Brain Health Imaging Centre
sylvain.houle@camhpet.ca About Dr. Sylvain Houle
Dr. James L. Kennedy
Scientific Director, Tanenbaum Centre for Pharmacogenetics
jim.kennedy@camh.ca About Dr. James L. Kennedy
Dr. Stefan Kloiber
Senior Scientist, General Adult Psychiatry and Health Systems Division
stefan.kloiber@camh.ca About Dr. Stefan Kloiber
Dr. Sanjeev Kumar
Scientist, Adult Neurodevelopment and Geriatric Psychiatry Division
sanjeev.kumar@camh.ca About Dr. Sanjeev Kumar
Dr. Meng-Chuan Lai
Senior Scientist, McCain Centre for Child, Youth and Family Mental Health and Azrieli Adult Neurodevelopmental Centre
meng-chuan.lai@camh.ca About Dr. Meng-Chuan Lai
ASCME Trial: Major National Study Aims to Advance Treatment for Methamphetamine Use Disorder
CAMH leads Ontario arm of largest clinical trial ever to help close the treatment gap
Read More
SUMMIT Trial News Release
New study reveals promising strategies to provide the necessary support and treatment more effectively and inclusively for pregnant and postpartum populations.
Read More
New CAMH-Developed Drug Shows Promise in Reversing Memory Loss for Early Alzheimer's Patients
Pre-clinical trial suggests treatment may slow the progression of Alzheimer’s and restore cognitive function.
Read More